(Q44256481)

1 December 2017

title

Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori? A randomized, controlled, prospective study (English)

1 reference

eradication of infectious diseases

1 December 2017

0 references

1 reference

Higuchi K

1

1 reference

1 December 2017

Fujiwara Y

2

1 reference

1 December 2017

Tominaga K

3

1 reference

1 December 2017

Watanabe T

4

1 reference

1 December 2017

Shiba M

5

1 reference

1 December 2017

Nakamura S

6

1 reference

1 December 2017

Oshitani N

7

1 reference

1 December 2017

Matsumoto T

8

1 reference

1 December 2017

Arakawa T

9

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

Alimentary Pharmacology & Therapeutics

1 December 2017

published in

1 reference

1 December 2017

volume

17

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

111-117

1 reference

Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01402.X

Does eradication of Helicobacter pylori alone heal duodenal ulcers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01402.X

Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01402.X

Peptic ulcer recurrence during maintenance therapy with H2-receptor antagonist following first-line therapy with proton pump inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01402.X

Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer--a European multicentre study. The European Rabeprazole Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01402.X

Antibacterial treatment of gastric ulcers associated with Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01402.X

Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01402.X

Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01402.X

The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01402.X

The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01402.X

Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01402.X

Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01402.X

10.1046/J.1365-2036.2003.01402.X

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference